| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | Butyrolactone I |
|---|
| Description | A Cdk1 inhibitor (IC50 = 20 μg/ml in PC-14 cells); induces dose-dependent G2/M arrest, inhibits DNA synthesis, and decreases Cdk1 protein expression in vitro; has antitumor effects in non-small lung, small cell lung, and prostate cancer cell lines (average IC50 = 50 μg/ml); inhibits in vitro Cdk1 phosphorylation of tau; inhibits in vivo phosphorylation of transcription factor E2F-1; increases biogenesis of the secondary metabolite lovastatin and conidiation in A. terreus, |
|---|
| Size | 1 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | 65372-42-1 olomoucin 4'-O-demethylversicolactone D aspergillus Cdk-1 G-2 E2F1 anti-tumor demethyl versicolactone NSCLC PC14 |
|---|
| Gene, Accession, CAS # | CAS: 87414-49-1 |
|---|
| Catalog # | 21765-1 |
|---|
| Price | |
|---|
| Order / More Info | Butyrolactone I from CAYMAN CHEMICAL COMPANY |
|---|
| Product Specific References | n/a |
|---|
| 產(chǎn)品資料 |
|
|